Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Dan Gebremedhin
AddedMar 31, 2024
UpdatedMay 31, 2026
Dan Gebremedhin

Dan Gebremedhin

Board Member, Votive Health

CrunchbaseLinkedIn

Dan Gebremedhin's Career

Votive Health
Votive Health

San Luis Obispo, CA, US

Board Member· Board
Somatus
Somatus

McLean, VA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Dan Gebremedhin's Career

Votive Health
Votive Health
Angel$2.8M152020San Luis Obispo, CA, US
Board Member· Board

Leadership at Votive Health

Torrie FieldsTorrie FieldsFounder

Similar to Votive Health

Inbound HealthInbound HealthMinneapolis, MN, USHealthcare, Home Healthest. 2022Inbound HealthMinneapolis, MN, US · est. 2022

Inbound Health: Full-stack provider enabling hospital and skilled nursing care at home.

Series B · $50M57
Vanna HealthVanna HealthSan Francisco, CA, USHealthcare Servicesest. 2021Vanna HealthSan Francisco, CA, US · est. 2021

Vanna Health: Online healthcare provider enhancing wellbeing for individuals with serious mental illness.

Series B · $29M22
Tomorrow HealthTomorrow HealthNew York City, NY, USHome Healthcareest. 2018Tomorrow HealthNew York City, NY, US · est. 2018

Tomorrow Health: Revolutionizing home healthcare through advanced technology.

Series B · $92.5M116
Accompany HealthAccompany HealthBethesda, MD, USHealthcare, Home Careest. 2022Accompany HealthBethesda, MD, US · est. 2022

Accompany Health: Comprehensive in-home healthcare provider, offering chronic illness management and 24/7 support.

Series A · $56M23
Somatus
Somatus
Series E$465.1M7902016McLean, VA, US
Board Member· Board

Leadership at Somatus

Dr. Ikenna Okezie W. MDDr. Ikenna Okezie W. MDFounder
Gregory GrunbergGregory GrunbergBoard Member
Anthony WeltersAnthony WeltersBoard Member
Julian HarrisJulian HarrisBoard Member

Similar to Somatus

Strive HealthStrive HealthDenver, CO, USDialysis, Kidney Careest. 2018Strive HealthDenver, CO, US · est. 2018

Strive Health: A value-based kidney care provider, integrating advanced technology and high-touch care teams.

Series C · $386M532
DaVitaDaVitaDenver, CO, USDialysis, Healthcareest. 1994DaVitaDenver, CO, US · est. 1994

US-based DaVita Inc. offers global kidney dialysis services for chronic kidney failure patients.

Public · $750M70k
Reset Kidney HealthReset Kidney HealthKidney Careest. 2022Reset Kidney Healthest. 2022

New Jersey-based medical organization providing swift, high-quality virtual kidney care.

Pre-Seed · $2.1M30
Monogram HealthMonogram HealthNashville, TN, USHome Healthcare, Kidney Careest. 2019Monogram HealthNashville, TN, US · est. 2019

Monogram Health: Evidence-based care for managing chronic kidney disease, prioritizing your life.

Series C · $555.1M548

Dan Gebremedhin's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Dan Gebremedhin

Daniel LynnDaniel LynnBoard Member · Revenue AnalyticsPhilip LewisPhilip LewisBoard Member · Advantum HealthDavid LaneDavid LaneFounder · Diamondhead VenturesChris StallmanChris StallmanBoard Member · Karamba SecurityChris AdamsChris AdamsBoard Member · GoodRxScott ColemanScott ColemanBoard Member · The/Studio